Brief: PAION granted formulation patent for remimazolam in the EU
Sept 28 (Reuters) - PAION AG PA8G.DE
* DGAP-NEWS: PAION AG: EUROPEAN PATENT OFFICE GRANTS
FORMULATION PATENT FOR REMIMAZOLAM IN THE EU
* PATENT PROTECTION UNTIL 2033 IN EU
Source text for Eikon: ID:nEQ7PL4lBa
Further company coverage: PA8G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PAION AG
See all newsBrief: Paion AG To Issue Approx 4.8 Mln Shares In Capital Increase With Subscription Rights
Brief: Paion AG Reports Developments On Commercial Activities In Europe
Brief: Paion Q1 EBITDA Up At EUR 15 Mln
Brief: Paion Grants Exclusive License To Cristália For Development And Commercialization Of Remimazolam In Latin America
Brief: Paion Announces Sebastian Werner As New CFO, Effective 1 June 2022